Department of Dermatology, School of Medicine, University of California, San Francisco, CA, USA.
Memorial University of Newfoundland School of Pharmacy H3440, 300 Prince Phillip Drive, St. John's, NL, A1B 3V6, Canada.
Regul Toxicol Pharmacol. 2022 Jul;132:105186. doi: 10.1016/j.yrtph.2022.105186. Epub 2022 May 10.
The concentration of a formulation, defined as the mass of applied chemical per unit of skin surface area, is a key variable of skin absorption. Often only one concentration is available in the literature, hence a general evidence-based theory could allow prediction of how altering the concentration would produce a linear, increased, or decreased relative permeation. Here, we group topical chemicals into groups of how they permeate the skin when we increase or decrease their concentrations per unit area and discuss why we would like to predict their permeability in ranges of studied concentrations.
Our research question is: How, if at all, do changes in surface chemical concentration affect percutaneous penetration/absorption in man? Specifically, as the drug concentration is relatively increased, is the rate or extent of absorption proportionally affected? And if so, how?
We searched PubMed, Google Scholar, the United States Food and Drug Administration, Scientific Committee on Consumer Safety, and the European Food Safety Authority for approved transdermal delivery systems from January 1965 to October 2020. Search terms included combinations of the following words: topical + [absorption/penetration] + cm + [human/man].
Of the nineteen chemicals identified, five (testosterone, hydrocortisone, benzoic acid, fluazifop-butyl and lindane) showed decreased percent absorbed with increased dose, one (2-butoxyethanol) showed decreased flux with increased concentration, and thirteen (Basic Brown 17, benzene in gasoline, benzophenone-3, benzoyl peroxide, boric acid, caffeine, climbazole, diclofenac, ethanolamines, ibuprofen, N-octylamine, 2-phenoxyethanol, 2-pyrrolidone) showed increased flux with increasing concentrations.
Dermal absorption depends on the interaction between the characteristics of the substance, the vehicle, and the skin. Without experiments investigating these characteristics, we cannot accurately predict the percent absorbed or flux of a formulation without in vitro or in vivo data. More experimental data, especially in vivo, is mandated before a highly efficient prediction model will be reached for validation.
我们的研究问题是:表面化学浓度的变化如何影响人体的经皮渗透/吸收?具体来说,随着药物浓度相对增加,吸收速率或程度是否成比例受到影响?如果是这样,会怎样?
我们检索了 1965 年 1 月至 2020 年 10 月美国食品和药物管理局、科学委员会消费者安全和欧洲食品安全局批准的透皮给药系统,检索词包括以下单词的组合:局部+[吸收/渗透]+cm+[人/男性]。
在所确定的十九种化学物质中,有五种(睾酮、氢化可的松、苯甲酸、氟唑草酯和林丹)随着剂量的增加,吸收的百分比降低,一种(2-丁氧基乙醇)随着浓度的增加,通量降低,有十三种(碱性棕 17、汽油中的苯、二苯甲酮-3、过氧化苯甲酰、硼酸、咖啡因、克霉唑、双氯芬酸、乙醇胺、布洛芬、正辛胺、2-苯氧乙醇、2-吡咯烷酮)随着浓度的增加通量增加。
皮肤吸收取决于物质特性、载体和皮肤之间的相互作用。如果没有实验来研究这些特性,我们就无法在没有体外或体内数据的情况下准确预测制剂的吸收率或通量。在建立一个高效的预测模型进行验证之前,需要更多的实验数据,特别是体内数据。